[Translation] A randomized, open-label, parallel-controlled Phase III clinical supplementary study of the same vaccine was conducted to evaluate the immune persistence of a 5-dose immunization schedule and a 4-dose immunization schedule (2 doses for the first injection) of freeze-dried human rabies vaccine (Vero cells) in healthy people aged 10 to 50 years.
主要研究目的 评价本试验冻干人用狂犬病疫苗采用5剂免疫程序和4剂免疫 程序在 10 岁~50 岁健康人群中接种的免疫持久性。 次要研究目的 评价本试验冻干人用狂犬病疫苗5剂免疫程序和4剂免疫程序 在 10 岁~50 岁健康人群中接种的免疫原性和安全性。
[Translation] Primary study objective: To evaluate the immune persistence of the 5-dose and 4-dose immunization schedules of the freeze-dried human rabies vaccine in healthy people aged 10 to 50 years. Secondary study objective: To evaluate the immunogenicity and safety of the 5-dose and 4-dose immunization schedules of the freeze-dried human rabies vaccine in healthy people aged 10 to 50 years.